Apex Research Group — Fair Oaks, California

Apex Research Group is a clinical research site located in Fair Oaks, California, United States 95628.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Apex Research Group has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Pneumococcal Disease, Cytomegalovirus Infection, COVID-19.

Sponsors: Pfizer, ModernaTX, Inc., Novavax.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fair Oaks

Browse all research sites in California · View every site in Fair Oaks

• Med Investigations
• GSK Investigational Site
• Pfizer Investigational Site
• Northern California Research Corp
• Novartis Investigative Site
• Sacramento Foot and Ankle Center
• Novo Nordisk Investigational Site
• Med Investigators
• Local Institution
• Amarin Investigational Site
• 511.130.01028 Boehringer Ingelheim Investigational Site

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Apex Research Group?

Apex Research Group has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Apex Research Group conducted?

Apex Research Group has 7 clinical trials on record, with 3 currently active. Their work covers Pneumococcal Disease, Cytomegalovirus Infection, COVID-19.

Is Apex Research Group accredited by Crixeo Clinical Trials?

Apex Research Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Apex Research Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.